Hot Papers in the Literature

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Annals of Internal Medicine

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/154099903321576592PMID 12859159
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study.

  2002cited by this paper
• Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.

  2001cited by this paper
• Use of statins and risk of fractures.

  2001cited by this paper
• Statins and their potential for osteoporosis.

  2001cited by this paper
• Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women.

  2000cited by this paper
• Oral statins and increased bone-mineral density in postmenopausal women.

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of fractures.

  2000cited by this paper
• HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients.

  2000cited by this paper
• Effect of Statins on Risk of Coronary Disease: A Meta-analysis of Randomized Controlled Trials

  2000cited by this paper
• The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society HMG-CoA Reductase Inhibitors Increase BMD in Type 2 Diabetes Mellitus Patients*

  1999cited by this paper
• Stimulation of bone formation in vitro and in rodents by statins.

  1999cited by this paper
• Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

  1999cited by this paper
• Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults.

  1998cited by this paper
• Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

  1998cited by this paper
• Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary

  1998cited by this paper
• Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women's Health Trial Feasibility Study in Minority Populations.

  1997cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION

  1992cited by this paper
• The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection

  1992cited by this paper
• The MOS 36-Item Short-Form Health Survey (SF-36)

  1992cited by this paper

• Cross-sectional and longitudinal associations between statin use and bone density: the Manitoba BMD registry

  2025cites this paper
• Hormonal Therapy and Cardiovascular Health

  2024cites this paper
• Efectos de los estatinas en la densidad mineral ósea de mujeres posmenopáusica de Córdoba, Argentina

  2024cites this paper
• The Effect of Statin Therapy on Bone Metabolism Markers and Mineral Density: Aa GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials

  2024cites this paper
• Advantages of statin usage in preventing fractures for men over 50 in the United States: National Health and Nutrition Examination Survey

  2024cites this paper
• Association of higher potency statin use with risk of osteoporosis and fractures in patients with stroke in a Korean nationwide cohort study

  2024cites this paper
• Race and Ethnicity and Fracture Prediction Among Younger Postmenopausal Women in the Women's Health Initiative Study.

  2023cites this paper
• The beneficial effects of tamoxifen on arteries: a key player for cardiovascular health of breast cancer patient.

  2023cites this paper
• Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults

  2023cites this paper
• Periostin-targeted SDSSD peptide decorated calcium phosphate nanocomposites incorporation with simvastatin for osteoporosis treatment

  2023cites this paper
• The Relationship Between Cancer and Functional and Structural Markers of Subclinical Atherosclerosis: A Systematic Review and Meta-Analysis

  2022cites this paper
• Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies.

  2022cites this paper
• Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis

  2022cites this paper
• Facts and ideas on statins with respect to their lipophilicity: a focus on skeletal muscle cells and bone besides known cardioprotection

  2022cites this paper
• Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control Study

  2021cites this paper
• A Retrospective Study on Statins and Post-stroke Patients: What About Functional Outcome and Follow-Up in a Stroke Rehabilitation Cohort?

  2021cites this paper
• Low dose hydrophilic statins are the preferred agents for females at risk of osteoporosis

  2021cites this paper
• Molecular enhancement of fracture healing - Is there a role for bone Morphogenetic Protein-2, Parathyroid Hormone, statins, or sclerostin-antibodies?

  2021cites this paper
• The Women's Health Initiative: A Landmark Resource for Skeletal Research Since 1992

  2020cites this paper
• Corilagin suppresses RANKL‐induced osteoclastogenesis and inhibits oestrogen deficiency‐induced bone loss via the NF‐κB and PI3K/AKT signalling pathways

  2020cites this paper
• Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.

  2020cites this paper
• Medications associated with fracture risk in patients with rheumatoid arthritis

  2019cites this paper
• Medications associated with fracture risk in patients with rheumatoid arthritis

  2019cites this paper
• Statin therapy: does sex matter?

  2019cites this paper
• Effects of Statins on Relative Risk of Fractures for Older Adults: An Updated Systematic Review With Meta-Analysis.

  2019cites this paper
• Atherosclerotic disease and cardiovascular risk factors in postmenopausal breast cancer survivors: a case–control study

  2019cites this paper
• Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor–Positive Early Breast Cancer

  2019cites this paper
• High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study

  2018cites this paper
• Association Between Cortical Bone Microstructure and Statin Use in Older Women

  2018cites this paper
• A Comparison of US and Canadian Osteoporosis Screening and Treatment Strategies in Postmenopausal Women

  2018cites this paper
• Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin

  2018cites this paper
• Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study

  2018cites this paper
• Statin use and hip fractures in U.S. kidney transplant recipients

  2017cites this paper
• Associations of Cardiovascular Risk Factors with Carotid Intima-Media Thickness in Middle-Age Adults and Elders

  2017cites this paper
• Associations of Parity, Breastfeeding, and Fractures in the Women's Health Observational Study.

  2017cites this paper
• Exposure to statins is associated to fracture risk reduction in elderly people with cardiovascular disease: evidence from the AIFA‐I‐GrADE observational project

  2017cites this paper
• Selective Activation of Estrogen Receptor α Activation Function-1 Is Sufficient to Prevent Obesity, Steatosis, and Insulin Resistance in Mouse.

  2017cites this paper
• Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen

  2016cites this paper
• Association of Central Versus Brachial Blood Pressure With Target-Organ Damage: Systematic Review and Meta-Analysis

  2016cites this paper
• Effects of 96 Weeks of Rosuvastatin on Bone, Muscle, and Fat in HIV-Infected Adults on Effective Antiretroviral Therapy

  2016cites this paper
• Efficacy of statins for osteoporosis: a systematic review and meta-analysis

  2016cites this paper
• Inhibition of macrophage CD 36 expression and cellular oxLDL accumulation by tamoxifen — A PPARγ dependent mechanism

  2016cites this paper
• Effects of Statins on Bone Mineral Density and Fracture Risk

  2016cites this paper
• Genetic Variant in ACVR2B Is Associated with Lean Mass.

  2016cites this paper
• Reply to F. Tomao et al.

  2015cites this paper
• Efficacy of Simvastatin in Bone Regeneration After Surgical Removal of Mandibular Third Molars: A Clinical Pilot Study

  2015cites this paper
• Tamoxifen induces the development of hernia in mice by activating MMP-2 and MMP-13 expression.

  2015cites this paper
• Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review.

  2015cites this paper
• Statin use and risk of fracture: a meta-analysis.

  2015cites this paper
• Statins and hip fracture risk in men: a population-based case-control study.

  2015cites this paper
• Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults

  2015cites this paper
• Novel applications of statins for bone regeneration.

  2015cites this paper
• Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.

  2015cites this paper
• The effects of locally applied simvastatin on an experimental mouse femur nonunion model.

  2014cites this paper
• Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis

  2014cites this paper
• Statins, bone metabolism and treatment of bone catabolic diseases.

  2014cites this paper
• Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy

  2014cites this paper
• Statins and osteoporosis: a latent promise.

  2014cites this paper
• Association of Statins and Risk of Fractures in a Military Health System

  2014cites this paper
• Tamoxifen inhibits macrophage FABP4 expression through the combined effects of the GR and PPARγ pathways.

  2013cites this paper
• Update on statins: hope for osteoporotic fracture healing treatment.

  2013cites this paper
• The Effects of a Psychosocial Behavioural Intervention on Arterial Health in Children

  2013cites this paper
• Anthracycline chemotherapy impairs the structure and diastolic function of the left ventricle and induces negative arterial remodelling.

  2013cites this paper
• Laxative use and incident falls, fractures and change in bone mineral density in postmenopausal women: results from the Women’s Health Initiative

  2013cites this paper
• Statin Use and Fracture Risk: Can We Quantify the Healthy-User Effect?

  2013cites this paper
• HMG-CoA reductase inhibitors (statins) and bone mineral density: a meta-analysis.

  2013cites this paper
• Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial.

  2013cites this paper
• Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial.

  2013cites this paper
• New Clues that May Link Osteoporosis to the Circulating Lipid Profile

  2013cites this paper
• Emerging Selective Estrogen Receptor Modulators

  2012cites this paper
• Data sources on drug safety evaluation: a review of recent published meta‐analyses

  2012cites this paper
• Mevalonate-suppressive dietary isoprenoids for bone health.

  2012cites this paper
• Heart drugs that affect bone.

  2012cites this paper
• Osteoporosis and polypharmacy

  2012cites this paper
• Effects of Tocotrienol and Lovastatin Combination on Osteoblast and Osteoclast Activity in Estrogen-Deficient Osteoporosis

  2012cites this paper
• Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells

  2012cites this paper
• Carotid intima-media thickness and laboratory parameters of atherosclerosis risk in patients with breast cancer.

  2012cites this paper
• Cardiovascular Side Effects of Radiotherapy in Breast Cancer

  2012cites this paper
• Effect of tamoxifen on the coronary vascular reactivity of spontaneously hypertensive female rats.

  2011cites this paper
• Induction of macrophage scavenger receptor type BI expression by tamoxifen and 4-hydroxytamoxifen.

  2011cites this paper
• Fluvastatin increases bone mineral density in postmenopausal women.

  2011cites this paper
• Intima-media thickness, myocardial perfusion and laboratory risk factors of atherosclerosis in patients with breast cancer treated with anthracycline-based chemotherapy

  2011cites this paper
• Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.

  2011cites this paper
• Low CD4 Count Is Associated With an Increased Risk of Fragility Fracture in HIV-Infected Patients

  2011cites this paper
• The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration

  2011cites this paper
• [Changes in bone mass with atorvastatin. BM AND AT study].

  2011cites this paper
• Synergistic Effect of Statins and Postmenopausal Hormone Therapy in the Prevention of Skeletal Fractures in Elderly Women

  2010cites this paper
• A Rational Guide to Reducing Fracture Risk in Dialysis Patients

  2010cites this paper
• Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

  2010cites this paper
• A systems approach to bone pathophysiology

  2010cites this paper
• Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials

  2010cites this paper
• Lipid Levels: A Link Between Cardiovascular Disease and Osteoporosis?

  2009cites this paper
• [Bone densitometry measurement and osteoporosis monitoring guide for the assessment of risk fracture].

  2009cites this paper
• Simvastatin locally applied from a biodegradable coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application.

  2009cites this paper
• [Primary prevention of cardiovascular diseases with statins in women].

  2009cites this paper
• Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats.

  2009cites this paper
• Atraumatic Fractures in Heart Failure

  2009cites this paper
• Non-Atheroprotective Effects of Statins

  2009cites this paper
• [The effect of statin treatment on inflammation in patients with metabolic syndrome].

  2009cites this paper
• Importance of arterial stiffness as cardiovascular risk factor for future development of new type of drugs

  2008cites this paper